Articles From: 2015/1/11 - Ayala Land Sells Shares, Raises PHP16 Billion for Expansion Plans to - PLShire to Acquire NPS Pharma as Further Step in Building a Leading Biotech


2015/1/11
By Cris Larano MANILA--Philippine property developer Ayala Land Inc. (ALI.PH) said Monday it raised 16 billion pesos ($356 million) through a shares placement to help fund capital expenditures and other real estate projects this year.
Sign-up for 2015/1/11 - Ayala Land Sells Shares, Raises PHP16 Billion for Expansion Plans investment picks
2015/1/11
By Ben Otto in Jakarta, Indonesia, and Richard C.
Sign-up for 2015/1/11 - Divers Recover One of AirAsia Flight 8501's Black Boxes investment picks
2015/1/11
PANGKALAN BUN, Indonesia--The underwater search for the black box data recorders from AirAsia Flight 8501 continued with limited success Sunday, a day after the aircraft's mangled tail section was pulled from the sea and loaded onto a ship.
Sign-up for 2015/1/11 - Hunt Continues for Black Boxes of AirAsia Plane investment picks
2014 Preliminary Estimates: Total revenues of $445 to $450 million, a 43% increase over 2013 (at midpoint) GAAP net income of $36 to $38 million, a 19% increase over 2013 (at midpoint) Adjusted net income of $53 to $55 million, a 49% increase over 2013 (at midpoint) 2015 Forecast: Total revenues of $510 to $540 million, a 17% increase over 2014 (at midpoints) GAAP net income of $50 to $60 million, a 49% increase over 2014 (at midpoints) Adjusted net income of $60 to $70 million, or 20% increase over 2014 (at midpoints) GAITHERSBURG, Md., Jan.
Sign-up for - Emergent BioSolutions Announces Preliminary 2014 Financial Results and Provides 2015 Financial Outlook investment picks
By Wallace Witkowski, MarketWatch SAN FRANCISCO (MarketWatch)--Big banks and other financial companies will dominate the start of earnings season this week, as the sector is expected to underperform the broader S&P 500 index in a quarter where expectations have already dropped considerably.
Sign-up for - MARKET SNAPSHOT: Banks Kick Off Low-expectation Earnings Season investment picks
2015/1/11
Dublin-based Shire plc on Sunday said it will acquire NPS Pharmaceuticals in a $5.2 billion deal, uniting two companies that focus on so-called orphan drugs and rare diseases.
Sign-up for 2015/1/11 - UPDATE: Ireland-based Shire to buy NPS for $5.2 billon, or $45 a share investment picks
By Wallace Witkowski, MarketWatch SAN FRANCISCO (MarketWatch)--Big banks and other financial companies will dominate the start of earnings season this week, as the sector is expected to underperform the broader S&P 500 index in a quarter where expectations have already dropped considerably.
Sign-up for - UPDATE: Banks kick off low-expectation earnings season investment picks
2015/01/11
Price of oil, interest rates, and global developments seen as key themes for the year.
Sign-up for 2015/01/11 - Readers' 2015 Market Forecast: Modest Gains, More Volatility investment picks
2015/1/11
Divers in Indonesia recovered one of two black boxes from AirAsia Flight 8501 on Monday, two days after the aircraft's mangled tail section was pulled from the sea and loaded onto a ship.
Sign-up for 2015/1/11 - Divers Recover One of AirAsia Plane's Black Boxes investment picks
2015/1/11
By Monica Houston-Waesch FRANKFURT--German car manufacturer BMW AG expects moderate growth in automobile markets in both China and the U.S. this year, the German daily Handelsblatt reported, citing board member Ian Robertson.
Sign-up for 2015/1/11 - BMW Expects Growth in U.S., China Auto Markets - Report investment picks
By MarketWatch, MarketWatch SAN FRANCISCO (MarketWatch)--Among the companies whose shares are expected to see active trading in Monday's session are Alcoa Inc., Tiffany & Co., and Burlington Stores Inc. Alcoa(AA) is projected to report fourth-quarter earnings of 27 cents a share, according to a consensus survey by FactSet.
Sign-up for - UPDATE: Alcoa, Tiffany, Burlington in Monday spotlight investment picks
By Bradley Hope After years of fighting for more trading to come back onto stock exchanges, Nasdaq OMX Group Inc. (NDAQ) is considering joining the dark side.
Sign-up for - Nasdaq looks to operate dark pools for banks investment picks
2015/1/11
By Mike Ramsey Last year was a good one for Nissan Motor Co.
Sign-up for 2015/1/11 - Nissan Hopes a Diesel Engine Lifts Its U.S. Truck Sales investment picks
2015/1/11
HILDEN , Germany and BEVERLY, Massachusetts , January 11, 2015 /PRNewswire/ -- Enzymatics products used in 80% of all global NGS sequencing reactions Strengthens QIAGEN's universal NGS product offering and strategy to offer complete NGS workflows from sample to insight Adds comprehensive R&D, manufacturing, formulation and analytical capabilities in enzymology Strategic partnership formed with ArcherDX, including technology and distribution rights to proprietary Archer NGS panel technology QIAGEN reaffirms fourth-quarter and full-year 2014 adjusted net sales guidance; charges to be taken related to acquisition and other restructuring activities QIAGEN N.V. (NASDAQ: QGEN, Frankfurt Prime Standard QIA) today announced the acquisition of the Enzyme Solutions Unit of Enzymatics, a world leader in the development, manufacturing, and OEM supply of enzymes essential
Sign-up for 2015/1/11 - QIAGEN Acquires Enzymatics Enzyme Solutions Unit, a Leading Enabler of NGS Applications investment picks
GES looks forward to connecting with attendees through a variety of touchpoints LAS VEGAS , Jan.
Sign-up for - GES Has Big Plans For PCMA's Convening Leaders investment picks
2015/01/11
Research suggests certain personality traits can influence a range of investment decisions and outcomes.
Sign-up for 2015/01/11 - Is Your Personality Impacting Your Portfolio? investment picks
2015/1/11
By Mike Ramsey Jaguar Land Rover, the British luxury car maker owned by Tata Motors Ltd, said global sales rose 9% to 462,678 in 2014.
Sign-up for 2015/1/11 - Jaguar Land Rover Says Global Sales Rose in 2014 investment picks
XenoPort (NASDAQ:XNPT) today reported an update on prescription trends and further development of HORIZANT ® (gabapentin enacarbil) Extended-Release Tablets, including feedback from the U.S. Food and Drug Administration (FDA) on development for treatment of alcohol use disorder (AUD). HORIZANT prescription trend highlights include: The number of nation-wide prescribed tablets for the 13 weeks ending December 19, 2014 was 1,256,082, an increase of 18% compared to the prior 13 weeks ending September 19, 2014 and an increase of 95% over the 13-week period ending December 20, 2013.* The rolling four-week average of prescribed tablets for the week ending December 19, 2014 was 100,742.* The current wholesale acquisition cost (WAC) price is $7.69 per tablet.
Sign-up for - XenoPort Provides Highlights of HORIZANT Prescription Trends and Update on Development for Alcohol Use Disorder investment picks
2015/1/11
By Richard C.
Sign-up for 2015/1/11 - AirAsia Flight 8501: Underwater Hunt Continues for Black Boxes investment picks
2015/1/11
By John D.
Sign-up for 2015/1/11 - GM To Use GM Financial Lending Arm For Subsidized Leases investment picks
2015/1/11
By Jonathan D.
Sign-up for 2015/1/11 - Shire to Buy NPS Pharmaceuticals for $5.2 Billion - 2nd Update investment picks
2015/1/11
By Dion Nissenbaum and Colleen McCain Nelson WASHINGTON--Attorney General Eric Holder said on Sunday the U.S. and its allies are working to determine if al Qaeda in the Arabian Peninsula played a direct role in orchestrating last week's attacks in Paris before deciding whether to retaliate against the militants in the Middle East.
Sign-up for 2015/1/11 - Holder Says U.S., Allies Probing Terror Group Links to Paris Attacks investment picks
2015/1/11
(FROM THE WALL STREET JOURNAL 1/12/15) By Sarah Krouse With oil prices tumbling 50% since June, the energy sector has garnered much of the blame for what is shaping up to be a lackluster fourth-quarter earnings season.
Sign-up for 2015/1/11 - Citi Shares The Blame investment picks
2015/1/11
By Jonathan D.
Sign-up for 2015/1/11 - Shire to Buy NPS Pharmaceuticals for $5.2 Billion - Update investment picks
EMERYVILLE, Calif., Jan.
Sign-up for - Adamas Pharmaceuticals Provides Review of 2014 and Previews Upcoming Business Drivers investment picks
2015/1/11
By Bradley Hope After years of fighting for more trading to come back onto stock exchanges, Nasdaq OMX Group Inc. is considering joining the dark side.
Sign-up for 2015/1/11 - Nasdaq Looks to Operate Dark Pools for Banks investment picks
By Jonathan D.
Sign-up for - Shire to buy NPS Pharmaceuticals for $5.2 billion investment picks
2015/1/11
By Christopher Mims I've seen some of the applications that will launch for the Apple Watch when it makes its debut as early as March, albeit in simulation, and some are extraordinary.
Sign-up for 2015/1/11 - How Apple Watch Could Spawn Wave of Tech Startups investment picks
2015/1/11
By John Letzing ZURICH--A Swiss banker denied assurances about his bail conditions will nonetheless take the unusual step of appearing in a U.S. court to face a charge of aiding American tax evasion, according to his attorney.
Sign-up for 2015/1/11 - Swiss Banker to Appear in U.S. Court to Face Tax Charges investment picks
DUBLIN and BEDMINSTER, New Jersey , January 11, 2015 /PRNewswire/ -- Transaction valued at $5.2 billion Enhances growth profile Shire plc (LSE: SHP, NASDAQ: SHPG) and NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) today announced that the companies have entered into a merger agreement pursuant to which Shire will acquire all the outstanding shares of NPS Pharma for $46.00 per share in cash, for a total consideration of approximately $5.2 billion .
Sign-up for - PLShire to Acquire NPS Pharma as Further Step in Building a Leading Biotech investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: 2015/1/11 - Ayala Land Sells Shares, Raises PHP16 Billion for Expansion Plans to - PLShire to Acquire NPS Pharma as Further Step in Building a Leading Biotech
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent